Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and anti-inflammatory compounds. Its structure supports conformational rigidity and enhanced metabolic stability, making it valuable in optimizing drug candidates for improved bioavailability and target selectivity. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the electron-withdrawing trifluoromethylphenylsulfonyl group that influences binding affinity and pharmacokinetic properties.